# Antibiotics

## Classes

| Class | Information |
| --- | --- |
| __Aminopenicillins__<br>Amoxicillin, Ampicillin, Piperacillin, Pivmecillinam | __Mechanism of Action:__ Inhibiting bacterial cell wall synthesis<br>__Bacteria:__ Gram-Positive + Gram-Negative<br><small>_Respiratory Tract Infections, Endocarditis, Urinary Tract Infections_</small> |
| __Beta-Lactamase-Inhibitor__<br>Sulbactam, Clavulanic Acid, Tazobactam | __Mechanism of Action:__ Biding and Degradation of the beta-lactamase<br>__Bacteria:__ Gram-Negative<br><small>_Staphylococcus (MRSA), Enterobacteriaceae (Klebsiella pneumoniae, Citrobacter, Proteus vulgaris, Morganella, Salmonella, Shigella, Escherichia coli), Haemophilus influenzae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, Mycobacterium tuberculosis_</small> |
| __Cephalosporins__<br><small>__Second Generation:__</small> Cefuroxim<br><small>__Third Generation:__</small> Ceftriaxon, Cefotaxim  | __Mechanism of Action:__ Inhibiting bacterial cell wall synthesis<br>__Bacteria:__ ↓ Gram-Positive + ↑ Gram-Negative<br><small>__Second Generation:__ _Haemophilus influenzae, Enterobacter aerogenes and some Neisseria, and Klebsiella pneumoniae_</small><br><small>__Third Generation:__ _Hospital-Acquired Infections, Penetrate the Central Nervous System, Meningitis (caused by pneumococci, meningococci), H. influenzae, and susceptible E. coli, Klebsiella, and penicillin-resistant N. gonorrhoeae_
| __Carbapenems__<br>Ertapenem, Meropenem, Imipenem | __Mechanism of Action:__ Inhibiting bacterial cell wall synthesis<br>__Bacteria:__ ↓ Gram-Positive + ↑↑ Gram-Negative<br><small>___Commonly used for the treatment of Severe or High-Risk bacterial Infections__, Enterobacteriaceace (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Citrobacter freundii, Proteus mirabilis, and Serratia marcescens), E. coli, K. pneumoniae,Pseudomonas aeruginosa and Acinetobacter species_
| __Macrolides__<br>Erythromycin, Clarithromycin, Azithromycin, Roxithromycin, Fosfomycin | __Mechanism of Action:__ Inhibit protein synthesis in bacteria<br>__Bacteria:__ Gram-Positive + ↓↓ Gram-Negative<br><small>_Streptococcus pneumoniae, Mycoplasma, Chlamydia, and Legionella pneumophilia, Mycobacteria, Beta-hemolytic Bacteria (streptococci, pneumococci, staphylococci, and enterococci)_</small>
| __Fluoroquinolones__<br>Ciprofloxacin, Moxifloxacin, Levofloxacin | __Mechanism of Action:__ Chemotherapeutic bactericidal drugs interfering with bacterial DNA replication<br>__Bacteria:__ Gram-Positive + Gram-Negative<br><small>_First line in serious acute cases of Pyelonephritis or bacterial Prostatitis, Hospital-Acquired Genitourinary Infections, Hospital-Acquired Pneumonia_</small> |
| __Aminoglycosides__<br>Gentamicin, Tobramycin, Amikacin | __Mechanism of Action:__ Inhibition of protein synthesis<br>__Bacteria:__ Gram-Negative (↑↑ Aerobes, ↓↓↓↓ Anaerobes)<br><small>_Sepsis, Complicated Intra-Abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Respiratory Tract Infections_</small> |
| __Tetracyclines__<br>Doxycyclin | __Mechanism of Action:__ Inhibiting protein synthesis<br>__Bacteria:__ Gram-Positive + Gram-Negative, Exceptions include Pseudomonas aeruginosa and Proteus spp.<br><small>_Acne, Cholera, Brucellosis, Plague, Malaria, and Syphilis_</small> |
| __Nitroimidazole__<br>Metronidazol, Tinidazole | __Mechanism of Action:__  Inhibiting nucleic acid synthesis<br>__Bacteria:__ Gram-Positive + Gram-Negative, Exceptions include Pseudomonas aeruginosa and Proteus spp.<br><small>_Acne, Cholera, Brucellosis, Plague, Malaria, and Syphilis_</small> |
| __Glycopeptides__<br>Vancomycin | – |
| __Antimycobacterial Agents__<br>Rimfapicin | __Mechanism of Action:__ Inhibiting bacterial DNA-dependent RNA synthesis

#### References

- [Wellington ICU Drug Manual](https://drug.wellingtonicu.com/PDF/WellingtonICUDrugManual.pdf)
- [Wellington ICU Drug Manual – Antibiotic Susceptibilities in Intensive Care](https://drug.wellingtonicu.com/PDF/App5-Antibiotics.pdf)

## Medication

| Name || GFR | Starting Dose | Further Doses |
| --- | --- | --- | --- | --- |
| Ampicillin/Sulbactam<br><small>Unacid</small> | i.v. | ≥ 30 mL/min | – | 3000 mg / 6 – 8 Hours |
| – &middot;&middot; – || 15 – < 30 mL/min | – | 3000 mg / 12 Hours |
| – &middot;&middot; – || 5 – < 15 mL/min | – | 3000 mg / 24 Hours |
| – &middot;&middot; – || < 5 mL/min | – | 3000 mg / 48 Hours |
| – &middot;&middot; – || Dialysis | 3000 mg | 1500 mg / 24 Hours<br>after Dialysis 1500 mg<br>Severe: 3000 mg / 24 Hours |
| Piperacillin/Tazobactam<br><small>Tazobac</small> | i.v. | ≥40 mL/min | – | 4500 mg / 6 Hours |
| – &middot;&middot; – || 20 – < 40 mL/min | – | 4500 mg / 8 Hours |
| – &middot;&middot; – || < 20 mL/min | – | 4500 mg / 12 Hours |
| – &middot;&middot; – || Dialysis | – | 4500 mg / 12 Hours<br>after Dyalisis 2250 mg |
| – &middot;&middot; – || CVVH | – | 4500 mg / 8 – 12 Hours
| Pivmecillinam | p.o. | – | – | 400 mg / 8 Hours |
| Cefuroxim | i.v. | ≥20 mL/min | – | 1500 mg / 8 Hours |
| – &middot;&middot; – || 10 – < 20 mL/min | – | 750 mg / 12 Hours |
| – &middot;&middot; – || < 10 mL/min | – | 750 mg / 24 Hours |
| – &middot;&middot; – || Dialysis | 1500 mg | 750 mg / 24 Hours<br>after Dialysis 750 mg |
| – &middot;&middot; – || CVVH | – | 750 – 1500 mg / 12 Hours |
| Ceftriaxon | i.v. | > 10 mL/min | – | 2000 mg / 12 – 24 Hours |
| – &middot;&middot; – || ≤ 10 mL/min | – | 2000 mg / 24 Hours |
| – &middot;&middot; – || Dialysis | – | 2000 mg / 24 Hours<br><small>_given after Dialysis_</small> |
| – &middot;&middot; – || CVVH | – | 2000 mg / 12 – 24 Hours<br><small>__OR__</small><br>4000 mg / 24 Hours | 
| Cefotaxim | i.v. | > 10 mL/min | – | 2000 mg / 8 Hours |
| – &middot;&middot; – || 5 – 10 mL/min | 2000 mg | 1000 mg / 8 Hours |
| – &middot;&middot; – || < 5 mL/min | 2000 mg | 500 mg / 12 Hours |
| – &middot;&middot; – || Dialysis | 2000 mg – 3000 mg | 1000 – 1500 mg / 12 Hours<br><small>_given after Dialysis_</small> |
| – &middot;&middot; – || CVVH | – | 2000 mg / 12 Hours<br>Severe: 2000 mg / 6 Hours |
| Ertapenem |
| Meropenem |
| Imipenem |
| Erythromycin |
| Clarithromycin | 
| Azithromycin | 
| Roxithromycin | p.o. | – | – | 300 mg / 24 Hours |
| Fosfomycin | p.o. | > 20 mL/min | 3000 mg x 1 | – |
| – &middot;&middot; – || < 20 mL/min | Contraindicated | – |
| Ciprofloxacin | p.o. | 30 – 60 mL/min | – | 500 mg / 12 Hours |
| – &middot;&middot; – || < 30 mL/min | 500 mg / 24 Hours |
| – &middot;&middot; – || Dialysis | – | 500 mg / 24 Hours<br><small>_given after Dialysis_</small><br>500 mg / 12 Hours<br><small>_if normal Hepatic Function_</small> |
| – &middot;&middot; – | i.v. |
| – &middot;&middot; – || 30 – 60 mL/min | – | 400 mg / 12 Hours |
| – &middot;&middot; – || < 300 mL/min | – | 400 mg / 24 Hours |
| – &middot;&middot; – || Dialysis | – | 400 mg / 24 Hours<br><small>_given after Dialysis_</small><br>400 mg / 12 Hours<br><small>_if normal Hepatic Function_</small> |
| – &middot;&middot; – || CVVH | – | 400 mg / 12 Hours<br>Severe: 400 mg / 8 Hours |
| Moxifloxacin | 
| Levofloxacin | – | > 50 mL/min | – | 500 mg / 12 – 24 Hours |
| – &middot;&middot; – || 20 – 50 mL/min | 500 mg | 250 mg / 12 – 24 Hours |
| – &middot;&middot; – || 10 – 19 mL/min | 500 mg | 125 mg / 12 – 24 Hours |
| – &middot;&middot; – || < 10 mL/min | 500 mg | 125 mg / 24 Hours |
| – &middot;&middot; – || Dialysis | 500 – 750 mg | 250 mg / 24 Hours<br><small>_given after Dialysis_</small> |
| – &middot;&middot; – || CVVH | 500 – 750 mg | 500 – 750 mg / 24 Hours |
| Gentamicin |
| Tobramycin |
| Amikacin |
| Doxycyclin |
| Metronidazol<br><small>Clont</small> |
| Tinidazole |
| Vancomycin |
| Rimfapicin |
| Nitrofurantoin | p.o. | > 60 mL/min | – | 100 mg / 8 Hours |
| – &middot;&middot; – || 45 – 50 mL/min | – | 100 mg / 12 Hours |
| – &middot;&middot; – || < 45 mL/min | – | Contraindicated |

#### References

- [Klinische Pharmakologie & Pharmakoepidemiologie, Universitätsklinikum Heidelberg](https://dosing.de/nierelst.php)